Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients
Christian Buske, Jorge J. Castillo, Jithma P. Abeykoon, Ranjana H. Advani, Suzanne O. Arulogun, Andrew R. Branagan, Xinxin Cao, Shirley D’Sa, Jian Hou, Prashant Kapoor, Efstathios Kastritis, Marie José Kersten, Véronique Leblond, Merav Leiba, Jeffrey Matous, Jonas Paludo, Lugui Qiu, Constantine S. Tam, Alessandra Tedeschi, Sheeba K. Thomas, Ibrahim Tohidi‐Esfahani, Marzia Varettoni, Josephine M. I. Vos, Ramón García‐Sánz, Jesús F. San Miguel, Meletios A Dimopoulos, Steven P. Treon, Judith Trotman (2023). Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients. , 60(2), DOI: https://doi.org/10.1053/j.seminhematol.2023.03.005.
Article43 days agoPRELIMINARY CLINICAL DATA FROM A PHASE 1B STUDY OF MAVORIXAFOR AND IBRUTINIB IN PATIENTS WITH WALDENSTRöM MACROGLOBULINEMIA WITH <i>MYD88</i> AND <i>CXCR4</i> MUTATIONS
Steven P. Treon, Christian Buske, Sheeba K. Thomas, Andrew R. Branagan, Meletios A Dimopoulos, J. J. Castillo, F. Garzon, Wenhao Tang, R. Ronan, Sean Seyffert, Vishvas Garg, S. Ali, Ana E Taveras, Anca Bădărău, Katarina Zmajkovicova, S. Maier, B. Maierhofer, J. Matouš (2021). PRELIMINARY CLINICAL DATA FROM A PHASE 1B STUDY OF MAVORIXAFOR AND IBRUTINIB IN PATIENTS WITH WALDENSTRöM MACROGLOBULINEMIA WITH <i>MYD88</i> AND <i>CXCR4</i> MUTATIONS. , 39(S2), DOI: https://doi.org/10.1002/hon.86_2881.
Article43 days agoPreliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with <i>MYD88</i> and <i>CXCR4</i> Mutations
Steven P. Treon, Christian Buske, Sheeba K. Thomas, Jorge J. Castillo, Andrew R. Branagan, Meletios A Dimopoulos, Maria Gavriatopoulou, Diego Cadavid, Felix T. Garzon, Weihua Tang, Sean Seyffert, Varun Garg, Shariq Ali, Arthur G. Taveras, Kelly Chen, Jeffrey Matous (2021). Preliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with <i>MYD88</i> and <i>CXCR4</i> Mutations. , 138(Supplement 1), DOI: https://doi.org/10.1182/blood-2021-144706.
Article43 days agoPreliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with <i>MYD88</i> and <i>CXCR4</i> Mutations
Steven P. Treon, Christian Buske, Sheeba K. Thomas, Jorge J. Castillo, Andrew R. Branagan, Meletios A Dimopoulos, Maria Gavriatopoulou, Diego Cadavid, Felix T. Garzon, Weihua Tang, Sean Seyffert, Varun Garg, Shariq Ali, Arthur G. Taveras, Kelly Chen, Jeffrey Matous (2021). Preliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with <i>MYD88</i> and <i>CXCR4</i> Mutations. , 138(Supplement 1), DOI: https://doi.org/10.1182/blood-2021-144706.
Article43 days agoTreatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
Meletios A Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A. Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramón García‐Sánz, Nikhil C. Munshi, Kenneth C. Anderson, Evangelos Terpos, Irene M. Ghobrial, Pierre Morel, David G. Maloney, Mathias Rummel, Véronique Leblond, Ranjana H. Advani, Morie A. Gertz, Charalampia Kyriakou, Sheeba K. Thomas, Bart Barlogie, Stephanie A. Gregory, Eva Kimby, Giampaolo Merlini, Steven P. Treon (2014). Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. , 124(9), DOI: https://doi.org/10.1182/blood-2014-03-565135.
Article43 days ago